Skip to main content

Table 1 Pluripotency marker expression of 2D and 3D expanded cells

From: Suspension culture improves iPSC expansion and pluripotency phenotype

 

2D planar

3D Suspension

p-value

Tra-1-60− Tra-1-81−

3.31% (IQR 0.95%)

0.00% (IQR 0.00%)

0.0476

Tra-1-60− Tra-1-81+

0.08% (IQR 0.04%)

0.00% (IQR 0.00%)

0.0476

Tra-1-60+ Tra-1-81−

11.05% (IQR 2.83%)

1.20% (IQR 0.87%)

0.0952

Tra-1-60+ Tra-1-81+

85.57% (IQR 3.75%)

98.80% (IQR 0.87%)

0.0952

Oct4− Nanog− Sox2−

5.47% (IQR 2.21%)

0.09% (IQR 0.09%)

0.0476

Oct4− Nanog− Sox2+

26.92% (IQR 5.98%)

1.13% (IQR 0.42%)

0.0079

Oct4− Nanog+ Sox2−

0.09% (IQR 0.04%)

0.01% (IQR 0.01%)

0.0873

Oct4− Nanog+ Sox2+

5.89% (IQR 0.85%)

3.95% (IQR 1.30%)

0.3095

Oct4+ Nanog− Sox2−

0.27% (IQR 0.16%)

0.01% (IQR 0.01%)

0.0873

Oct4+ Nanog− Sox2+

6.46% (IQR 2.19%)

0.25% (IQR 0.08%)

0.0079

Oct4+ Nanog+ Sox2−

0.32% (IQR 0.15%)

0.00% (IQR 0.00%)

0.0476

Oct4+ Nanog+ Sox2+

52.45% (IQR 5.61%)

94.25% (IQR 1.40%)

0.0079

  1. Quantitative pluripotency marker expression on day 5 characterized by flow cytometry of cells expanded in 2D planar and 3D suspension conditions with percent of total cells and p-value